Table of Contents

2019-2024 Global Biopharmaceutical Excipients Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Biopharmaceutical Excipients Consumption 2014-2024
  • 2.1.2 Biopharmaceutical Excipients Consumption CAGR by Region
• 2.2 Biopharmaceutical Excipients Segment by Type
  • 2.2.1 Solubilizers& Surfactants/Emulsifiers
  • 2.2.2 Polyols
  • 2.2.3 Carbohydrates
  • 2.2.4 Other
• 2.3 Biopharmaceutical Excipients Consumption by Type
  • 2.3.1 Global Biopharmaceutical Excipients Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Biopharmaceutical Excipients Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Biopharmaceutical Excipients Sale Price by Type (2014-2019)
• 2.4 Biopharmaceutical Excipients Segment by Application
  • 2.4.1 Biopharmaceutical Downstream
  • 2.4.2 Biopharmaceutical Upstream
• 2.5 Biopharmaceutical Excipients Consumption by Application
  • 2.5.1 Global Biopharmaceutical Excipients Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Biopharmaceutical Excipients Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Biopharmaceutical Excipients Sale Price by Application (2014-2019)

3 Global Biopharmaceutical Excipients by Manufacturers

• 3.1 Global Biopharmaceutical Excipients Sales Market Share by Manufacturers
  • 3.1.1 Global Biopharmaceutical Excipients Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Biopharmaceutical Excipients Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Biopharmaceutical Excipients Revenue Market Share by Manufacturers
  • 3.2.1 Global Biopharmaceutical Excipients Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Biopharmaceutical Excipients Sale Price by Manufacturers
• 3.4 Global Biopharmaceutical Excipients Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Biopharmaceutical Excipients Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Biopharmaceutical Excipients Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Biopharmaceutical Excipients by Regions

• 4.1 Biopharmaceutical Excipients by Regions
  • 4.1.1 Global Biopharmaceutical Excipients Consumption by Regions
  • 4.1.2 Global Biopharmaceutical Excipients Value by Regions
• 4.2 Americas Biopharmaceutical Excipients Consumption Growth
• 4.3 APAC Biopharmaceutical Excipients Consumption Growth
• 4.4 Europe Biopharmaceutical Excipients Consumption Growth
• 4.5 Middle East & Africa Biopharmaceutical Excipients Consumption Growth

5 Americas

• 5.1 Americas Biopharmaceutical Excipients Consumption by Countries
  • 5.1.1 Americas Biopharmaceutical Excipients Consumption by Countries (2014-2019)
  • 5.1.2 Americas Biopharmaceutical Excipients Value by Countries (2014-2019)
• 5.2 Americas Biopharmaceutical Excipients Consumption by Type
• 5.3 Americas Biopharmaceutical Excipients Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Biopharmaceutical Excipients Consumption by Countries
  • 6.1.1 APAC Biopharmaceutical Excipients Consumption by Countries (2014-2019)
  • 6.1.2 APAC Biopharmaceutical Excipients Value by Countries (2014-2019)
• 6.2 APAC Biopharmaceutical Excipients Consumption by Type
• 6.3 APAC Biopharmaceutical Excipients Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Biopharmaceutical Excipients by Countries
  • 7.1.1 Europe Biopharmaceutical Excipients Consumption by Countries (2014-2019)
  • 7.1.2 Europe Biopharmaceutical Excipients Value by Countries (2014-2019)
• 7.2 Europe Biopharmaceutical Excipients Consumption by Type
• 7.3 Europe Biopharmaceutical Excipients Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Biopharmaceutical Excipients by Countries
  • 8.1.1 Middle East & Africa Biopharmaceutical Excipients Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Biopharmaceutical Excipients Value by Countries (2014-2019)
• 8.2 Middle East & Africa Biopharmaceutical Excipients Consumption by Type
• 8.3 Middle East & Africa Biopharmaceutical Excipients Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Biopharmaceutical Excipients Distributors
• 10.3 Biopharmaceutical Excipients Customer

11 Global Biopharmaceutical Excipients Market Forecast

• 11.1 Global Biopharmaceutical Excipients Consumption Forecast (2019-2024)
• 11.2 Global Biopharmaceutical Excipients Forecast by Regions
  • 11.2.1 Global Biopharmaceutical Excipients Forecast by Regions (2019-2024)
  • 11.2.2 Global Biopharmaceutical Excipients Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Biopharmaceutical Excipients Forecast by Type
• 11.8 Global Biopharmaceutical Excipients Forecast by Application

12 Key Players Analysis

• 12.1 BASF SE
  • 12.1.1 Company Details
  • 12.1.2 Biopharmaceutical Excipients Product Offered
  • 12.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 BASF SE News
• 12.2 ABITEC Corp
  • 12.2.1 Company Details
  • 12.2.2 Biopharmaceutical Excipients Product Offered
  • 12.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 ABITEC Corp News
• 12.3 Colorcon, Inc
  • 12.3.1 Company Details
  • 12.3.2 Biopharmaceutical Excipients Product Offered
  • 12.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Colorcon, Inc News
• 12.4 DFE Pharma
  • 12.4.1 Company Details
  • 12.4.2 Biopharmaceutical Excipients Product Offered
  • 12.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 DFE Pharma News
• 12.5 Meggle AG
  • 12.5.1 Company Details
  • 12.5.2 Biopharmaceutical Excipients Product Offered
  • 12.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Meggle AG News
• 12.6 Pharmonix Biological
  • 12.6.1 Company Details
  • 12.6.2 Biopharmaceutical Excipients Product Offered
  • 12.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Pharmonix Biological News
• 12.7 Roquette
  • 12.7.1 Company Details
  • 12.7.2 Biopharmaceutical Excipients Product Offered
  • 12.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Roquette News
• 12.8 Sigachi Industries
  • 12.8.1 Company Details
  • 12.8.2 Biopharmaceutical Excipients Product Offered
  • 12.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sigachi Industries News
• 12.9 Signet Chemical Corporation
  • 12.9.1 Company Details
  • 12.9.2 Biopharmaceutical Excipients Product Offered
  • 12.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Signet Chemical Corporation News
• 12.10 Spectrum Chemical Manufacturing Corp
  • 12.10.1 Company Details
  • 12.10.2 Biopharmaceutical Excipients Product Offered
  • 12.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Spectrum Chemical Manufacturing Corp News
• 12.11 SPI Pharma

13 Research Findings and Conclusion

According to this study, over the next five years the Biopharmaceutical Excipients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biopharmaceutical Excipients business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.

This study considers the Biopharmaceutical Excipients value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Solubilizers& Surfactants/Emulsifiers
Polyols
Carbohydrates
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Biopharmaceutical Downstream
Biopharmaceutical Upstream

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BASF SE
ABITEC Corp
Colorcon, Inc
DFE Pharma
Meggle AG
Pharmonix Biological
Roquette
Sigachi Industries
Signet Chemical Corporation
Spectrum Chemical Manufacturing Corp
SPI Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Biopharmaceutical Excipients consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biopharmaceutical Excipients market by identifying its various subsegments.
Focuses on the key global Biopharmaceutical Excipients manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharmaceutical Excipients with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biopharmaceutical Excipients submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.